This suggests that among both genders, the LHR as an inexpensive and easy‐to‐access marker has a better diagnostic performance and could be promising alternatives to the traditional and expensive inflammatory markers such as hs‐CRP for the evaluation of inflammation in subjects with MetS. This evidence concerns the gene CRP and metabolic syndrome.